Tempest Therapeutics, Inc. (TPST) Gross margin 2016–2017
Tempest Therapeutics, Inc. (TPST) gross margin by fiscal year — reported gross profit divided by reported revenue.
-167.8%FY2017 · since FY2016: -727.1% → -167.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | -167.8% | +559.3 pp |
| FY2016 | -727.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TPST financial trends
TPST RevenueTPST Net incomeTPST Net marginTPST Gross profitTPST Operating incomeTPST Operating marginTPST Operating cash flowTPST Free cash flowTPST Capital expendituresTPST Return on equityTPST Stock buybacksTPST Dividends paidTPST Total assetsTPST Total liabilitiesTPST Shareholders’ equityTPST overview →